- Report
- October 2025
- 120 Pages
Global
From €5273EUR$5,950USD£4,524GBP
- Report
- August 2025
- 150 Pages
Global
From €5273EUR$5,950USD£4,524GBP
- Report
- June 2026
- 147 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- June 2026
- 145 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- April 2026
- 140 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- April 2026
- 137 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- May 2026
- 188 Pages
Global
From €3988EUR$4,500USD£3,422GBP
- Report
- August 2026
- 278 Pages
Global
From €5184EUR$5,850USD£4,448GBP
- Report
- August 2026
- 185 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 189 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 196 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 196 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 184 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 185 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 194 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 185 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 199 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 181 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 199 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- January 2026
- 186 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP

The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions.
The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests.
Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more